Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Cytokine, 3(13), p. 174-178

DOI: 10.1006/cyto.2000.0817

Links

Tools

Export citation

Search in Google Scholar

Interleukin 1β (IL-1β) action in porcine thyroid cells involves the ceramide signalling pathway

Journal article published in 2001 by C. Schneider ORCID, N. Delorme, H. El Btaouri, W. Hornebeck, B. Haye, L. Martiny
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Interleukin 1 beta (IL-1beta) is often associated with thyroidal autoimmune diseases. This cytokine has been largely described to trigger an important biological signalling pathway: the sphingomyelin/ceramide pathway. In this report we show that IL-1beta induces ceramide formation and sphingomyelin degradation in porcine thyroid cells via the activation of a neutral sphingomyelinase. Among the potential targets of IL-1beta and ceramides action, we have investigated the role of an atypical protein kinase C (PKC), the PKC zeta. We show that both IL-1beta and ceramides lead to an increase of PKCzeta activity. All these results suggest an important role for ceramides and IL-1beta in regulation of thyroid function, leading to cell survival or to apoptosis.